These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 107146)
1. Effect of human serum thymic factor on immature T lymphocytes in acute leukemia and other hematologic malignancies. Cavdar AO; Ozger Topuz U; Erten J; Losio M; Erten M; Astaldi G Isr J Med Sci; 1978 Dec; 14(12):1216-20. PubMed ID: 107146 [TBL] [Abstract][Full Text] [Related]
2. E-rosette forming lymphocytes in acute leukemia before and after cell incubation with human serum thymic factor. Ozger Topuz U; Okçuoglu Cavdar A; Astaldi G Boll Ist Sieroter Milan; 1977 Nov; 56(5):449-56. PubMed ID: 304352 [TBL] [Abstract][Full Text] [Related]
3. [Use of thymus hormone in the demonstration of acute T-null cell lymphocytic leukemia]. Ozger Topuz U; Astaldi G; Cavdar A Minerva Med; 1978 Apr; 69(18):1275-80. PubMed ID: 307199 [TBL] [Abstract][Full Text] [Related]
4. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease. Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid-hormone-related peptide in hematologic malignancies. Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726 [TBL] [Abstract][Full Text] [Related]
7. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease. Zółtowska A; Arendt M; Gan J Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594 [TBL] [Abstract][Full Text] [Related]
8. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499 [TBL] [Abstract][Full Text] [Related]
9. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384 [TBL] [Abstract][Full Text] [Related]
10. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease]. Meier EC; Grob PJ Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059 [No Abstract] [Full Text] [Related]
11. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies]. Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251 [TBL] [Abstract][Full Text] [Related]
12. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin. Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376 [TBL] [Abstract][Full Text] [Related]
13. Thymic humoral factor in the assessment of T lymphocytics in a patient with T cell chronic lymphocyte leukemia. Douer D; Shohat B; Djaldetti M; Trainin N; Pinkhas J Isr J Med Sci; 1978 Aug; 14(8):870-5. PubMed ID: 29860 [TBL] [Abstract][Full Text] [Related]
14. Human serum thymic factor in detecting acute T cell leukemia. Ozger Topuz U; Cavdar AO; Astaldi G Bibl Haematol; 1978; 45():152-5. PubMed ID: 311636 [TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts. Borella L; Sen L; Casper JT J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669 [TBL] [Abstract][Full Text] [Related]
16. Hormonal changes in patients with haematological malignancies. Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194 [TBL] [Abstract][Full Text] [Related]
17. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease. Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627 [TBL] [Abstract][Full Text] [Related]
18. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients. Michalevicz R; Many A; Ramot B; Trainin N Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342 [TBL] [Abstract][Full Text] [Related]
19. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders. Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the immunological indices of the peripheral blood and lymph nodes in lymphogranulomatosis in children]. Voĭtenkov BO; Gavrilenkova LP Vopr Onkol; 1985; 31(7):83-7. PubMed ID: 3875182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]